Related Experiment Video
Updated: Jul 20, 2026
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)
M F Piepoli1, C Davos, D P Francis
1Cardiac Medicine, Royal Brompton Hospital, Imperial College of Science Technology and Medicine, London.
BMJ (Clinical Research Ed.)
|January 20, 2004
Summary
Exercise training significantly improves survival for patients with heart failure. This meta-analysis of randomized trials shows a clear reduction in mortality, indicating exercise programs are safe and beneficial.
Area of Science:
- Cardiology
- Exercise Physiology
- Clinical Trials
Background:
- Heart failure due to left ventricular systolic dysfunction is a significant clinical challenge.
- The role of exercise training in managing heart failure patients requires robust evidence.
Purpose of the Study:
- To evaluate the impact of exercise training on survival rates in patients diagnosed with heart failure.
- To synthesize data from randomized controlled trials to determine the efficacy of exercise interventions.
Main Methods:
- A collaborative meta-analysis was conducted, pooling individual patient data from randomized parallel group controlled trials.
- Inclusion criteria specified trials of at least eight weeks duration with survival data for a minimum of three months.
- Nine datasets comprising 801 patients (395 exercise, 406 control) were analyzed.
Main Results:
- Over a mean follow-up of 705 days, exercise training was associated with a significant reduction in all-cause mortality (hazard ratio 0.65, P=0.015).
- The combined endpoint of death or hospital admission was also significantly reduced (hazard ratio 0.72, P=0.011).
- No significant subgroup-specific treatment effects were identified.
Conclusions:
- Supervised exercise training programs for heart failure patients are not dangerous and demonstrate a clear overall reduction in mortality.
- Future research should concentrate on optimizing exercise program design and identifying specific patient populations who would benefit most.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:17Exercise and Cardiac Output
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Sustained exercise increases the muscles' oxygen demand, which can be met...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.